151 Symptom management in end stage liver disease – results of a regional palliative care network survey by Ting, G et al.
SYMPTOM MANAGEMENT IN END STAGE LIVER DISEASE:  
RESULTS OF A REGIONAL PALLIATIVE CARE NETWORK SURVEY 
Grace Ting, Diane Foster, Sarah Fradsham, Joanna Henry, Jenny Hill, Susan Howarth, Lynn Owens, Katherine Rugen, Andrew Khodabukus. 
Cheshire and Merseyside Palliative and End of  Life Care Network Audit Group 
Contact : ghlting@doctors.net.uk 
•  Alcohol-related disease accounts for 37% of  liver disease deaths. 
•  90% of  people who die from liver disease are under 70 years old. 
•  Over 70% of  people with liver disease die in hospital. 
A multiprofessional clinical practice survey and a retrospective case note review  was carried out across a 
regional palliative care network in North West England. 
54% had their first contact with specialist 
palliative care services 7 days or fewer before 
they died. 
Recognition of  the dying patient with end stage liver failure can be a challenge due to the fluctuating nature of  
the condition. Healthcare professionals in this survey highlighted a need for training in pharmacology of  drugs 
used in end stage liver disease. A regional guideline has been written to guide healthcare professionals in the 
management of  symptoms in patients with end stage liver disease. 
METHOD 
RESULTS 
A challenge identified in the clinical 
practice survey was management of  
agitation and delirium in this cohort of  
patients. 
CONCLUSION 
51 healthcare professionals who responded 
to the survey highlighted training in 
pharmacology of  drugs used in end stage 
liver failure as a top priority. 
